(Q35963349)

11 August 2017

Impact of oral cholera vaccines in cholera-endemic countries: A mathematical modeling study (English)

1 reference

11 August 2017

0 references

Jong-Hoon Kim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993337%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Colleen Burgess

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993337%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

English

0 references

publication date

15 March 2016

1 reference

11 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993337%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993337%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993337%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

2113-2120

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993337%20AND%20SRC:MED&resulttype=core&format=json

Updated global burden of cholera in endemic countries

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Vaccines in the time of cholera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Effectiveness of an oral cholera vaccine campaign to prevent clinically-significant cholera in Odisha State, India.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Effectiveness of reactive oral cholera vaccination in rural Haiti: a case-control study and bias-indicator analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Feasibility of a preventive mass vaccination campaign with two doses of oral cholera vaccine during a humanitarian emergency in South Sudan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Use of Vibrio cholerae vaccine in an outbreak in Guinea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

First outbreak response using an oral cholera vaccine in Africa: vaccine coverage, acceptability and surveillance of adverse events, Guinea, 2012.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Feasibility of mass vaccination campaign with oral cholera vaccines in response to an outbreak in Guinea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Use of oral cholera vaccine in Haiti: a rural demonstration project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the Odisha model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Infection: mass vaccination is feasible in response to cholera epidemics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Use of oral cholera vaccines in an outbreak in Vietnam: a case control study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Urban cholera transmission hotspots and their implications for reactive vaccination: evidence from Bissau city, Guinea bissau

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Modeling the effect of water, sanitation, and hygiene and oral cholera vaccine implementation in Haiti

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010-2011.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

The case for reactive mass oral cholera vaccinations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Controlling endemic cholera with oral vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Comparative effectiveness of different strategies of oral cholera vaccination in bangladesh: a modeling study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Considerations around the introduction of a cholera vaccine in Bangladesh.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

The Components of Predation as Revealed by a Study of Small-Mammal Predation of the European Pine Sawfly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Reassessment of the 2010-2011 Haiti cholera outbreak and rainfall-driven multiseason projections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Transmission dynamics and control of cholera in Haiti: an epidemic model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Modelling cholera epidemics: the role of waterways, human mobility and sanitation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Hyperinfectivity: a critical element in the ability of V. cholerae to cause epidemics?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Cholera epidemic in Haiti, 2010: using a transmission model to explain spatial spread of disease and identify optimal control interventions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Identifiability and estimation of multiple transmission pathways in cholera and waterborne disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Descriptive characterization of the 2010 cholera outbreak in Nigeria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

The burden of cholera in Uganda.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

The global burden of cholera.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Vaccination strategies for epidemic cholera in Haiti with implications for the developing world

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

5 year efficacy of a bivalent killed whole-cell oral cholera vaccine in Kolkata, India: a cluster-randomised, double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Natural cholera infection-derived immunity in an endemic setting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Climate and socioeconomic influences on interannual variability of cholera in Nigeria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Cholera and climate: revisiting the quantitative evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Effectiveness of mass oral cholera vaccination in Beira, Mozambique

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Study designs for evaluating different efficacy and effectiveness aspects of vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Estimating the reproductive numbers for the 2008-2009 cholera outbreaks in Zimbabwe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Oral cholera vaccine development and use in Vietnam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

7 January 2021

Cholera's western front

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

Oral cholera vaccines in endemic countries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.004

10.1016/J.VACCINE.2016.03.004

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26993337%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference